U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Proteus syndrome

Summary

Excerpted from the GeneReview: Proteus Syndrome
Proteus syndrome (PS) is characterized by progressive segmental or patchy overgrowth most commonly affecting the skeleton, skin, adipose, and central nervous systems. In most individuals PS has modest or no manifestations at birth, develops and progresses rapidly beginning in the toddler period, and relentlessly progresses through childhood, causing severe overgrowth and disfigurement. It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism.

Available tests

29 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Genes See tests for all associated and related genes

  • Also known as: AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA, AKT1
    Summary: AKT serine/threonine kinase 1

Clinical features

Help

Show allHide all

Suggested reading

  • Lindhurst et al., 2011
    A mosaic activating mutation in AKT1 associated with the Proteus syndrome.
  • Turner et al., 2004
    Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases.
  • Biesecker et al., 1998
    Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation.

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.